Analyst Research Report Snapshot

Title:

ASSURA GROUP - GETTING HEALTHIER

Price:

$10.00

Provider:

Edison Investment Research

Date:

30 Nov 2009

Pages:

2

Type:

AcrobatPDF

Companies referenced:

AGRP.L

Available for Immediate Download
Summary:

Interim results to 30 September showed substantial progress in building the health franchise but a strategic shift may be underway. Pharmacy had a £15.2m turnover, up 25%, and made a tiny operating loss; it could be profitable from FY10 overall. Assura now has 68 NHS services running or at preferred bidder stage, a 23% rise since June. However, GPCos may be spun out to cut losses and spare cash, but at the expense of long-term growth. Property revenues were £11.9m on a £333m portfolio. The shares are at a discount to the basic 58.14p NAV (adjusted 654p). FOR MORE INFORMATION ON THE ATTACHED RESEARCH PLEASE CALL 020 3077 5700, EMAIL RESEARCH@EDISONINVESTMENTRESEARCH.CO.UK OR VISIT WWW.EDISONINVESTMENTRESEARCH.CO.UK

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.